
GLP-1 Dosage Chart (2026): Every US Dose
Every US weight-loss GLP-1 dose ladder on one printable chart, from the FDA labels: Zepbound, Wegovy, Wegovy HD, the Wegovy pill and Foundayo.
Read more →
Zepbound Savings Card 2026: Who Qualifies, What You Pay
Who can use the Zepbound savings card, what it takes off a pen or KwikPen each month, its monthly and yearly caps, and what to do on Medicare or with no insurance. From Lilly's own terms.
Read more →
How Much Does Zepbound Cost Without Insurance? (2026)
What Zepbound costs without insurance: LillyDirect vial and KwikPen prices by dose, the 45-day refill rule, a full year's cost, and the Medicare, HSA and insurance routes.
Read more →
Wegovy Savings Card 2026: Who Qualifies, What You Pay
Who can use the Wegovy savings card, what it takes off the pill, pen and Wegovy HD each month, how to get it, and what to do on Medicare, Medicaid or with no insurance.
Read more →
How Much Does Wegovy Cost Without Insurance? (2026)
What Wegovy costs without insurance: self-pay prices for the pill, pen and Wegovy HD by dose, the new-patient offer, a full year's cost, and the Medicare, HSA and insurance routes.
Read more →
Zepbound Dosage Schedule and Dose Chart (2026)
The Zepbound dosage schedule from the FDA label: 2.5 mg to start, steps to 15 mg, maintenance doses, pens, vials and the KwikPen, missed doses, side effects and storage.
Read more →
Wegovy Dose Chart (2026): Pen, HD and Pill
Every Wegovy dose from the FDA label: the pen's 0.25 to 2.4 mg steps, Wegovy HD 7.2 mg, the pill's 1.5 to 25 mg steps, missed doses, switching and side effects.
Read more →
What to Eat on Zepbound: Easy Foods When Nothing Sounds Good
What to eat on Zepbound, from the 2025 joint nutrition advisory and the FDA label: small regular meals, protein, easy foods for low-appetite days, what makes nausea worse, constipation and fluids. No calorie counting.
Read more →
Eating Less but Gaining Weight? Why Under-Eating Backfires
No breakfast, a small lunch, then a Magnum and a glass of wine at night? Why under-eating backfires, how far off calorie labels can be, and the six pillars of health. Inspired by nutritionist Dr Federica Amati.
Read more →
How to Improve Self-Esteem: The Rules You Live By, and How to Loosen Them
Rules like 'If I eat after 8pm, I've failed' or 'I must be slim to be liked' keep self-esteem low. How CBT spots and loosens them, what the research shows, and a free two-page worksheet.
Read more →
Why Regular Eating Works: Hunger, Hormones and the Binge-Restrict Cycle
Eating every three to four hours is the first step in CBT for binge eating. The research behind it, where it's solid and where it isn't, and why it matters when you come off a GLP-1.
Read more →
Why Your Body Needs Carbs and Fat, Even on a GLP-1
Carbs and fat both do jobs your body can't skip. What the evidence says about fibre, saturated fat, low-carb vs low-fat, and eating well on a GLP-1.
Read more →
Set Point Theory: Why Your Weight Moves, Why It Pushes Back, and Why That Isn't a Verdict on You
Why the scale jumps day to day, why your body defends its weight, and what the GLP-1 withdrawal trials show. Set point science, minus the fear.
Read more →
CBT for Eating Disorders: How Therapy and Carbs Support Weight Loss
Food obsession behaves like addiction, but abstinence can't be the cure. What the Fairburn CBT model actually says, why carbs matter for mood, and how to track without being controlled by it.
Read more →
Low Calorie Snacks Under 50 Calories: Satisfy Cravings Without Breaking Your Budget
44 snacks under 50 calories, built from the satiety research: protein-first picks, the potato trick, and portions in grams so they read the same in the UK, Ireland, Australia and the US.
Read more →
Amycretin (Zenagamtide): What the Trials Actually Show
Novo Nordisk's GLP-1 and amylin co-agonist, in both injection and tablet form, and now formally renamed. The published Lancet figures, why the placebo arms matter, and the UK trial sites recruiting now.
Read more →
MariTide: The Monthly Injection That Blocks GIP
Amgen's monthly injection blocks the receptor Mounjaro (Zepbound in the US) switches on, and still takes weight off. The phase 2 figures, the two numbers everyone quotes, and what the paradox means for the next decade of obesity drugs.
Read more →
Why Writing It Down Works: The Science of Food Diaries and Weight Loss
In a 1,685-person trial, people who kept daily food records lost twice as much as those who kept none. The evidence for food diaries, how little time they take, and why they matter more on a GLP-1, not less.
Read more →
GLP-1 Weight-Loss Plateau: Why It Stalls, and What Actually Restarts It
The curve flattens in the trials too. What metabolic adaptation, intake drift, dose ceilings and lost muscle each contribute to a stall, and what the evidence says restarts it.
Read more →
Coming Off a GLP-1 Without Regaining: The Maintenance Playbook
Two-thirds of the weight came back within a year in the STEP 1 extension, where the drug and the lifestyle programme both stopped at once. What that study really measured, and the six things worth having in place before your last dose.
Read more →
Protecting Muscle on a GLP-1: The Protein and Resistance-Training Protocol
A quarter to two-fifths of medically induced weight loss can be lean mass, and that ratio is changeable. The g/kg numbers the evidence supports, the training dose, and how to hit both on a suppressed appetite.
Read more →
Can You Breathe Into a Gadget Instead of Counting Calories? An Honest Look at Lumen
Lumen measures which fuel you're burning, not how many calories you ate. What the science actually says, how strong the validation really is, the honest pros and cons, and who it suits.
Read more →
The Obesity Code by Jason Fung: What It Gets Right, and Where the Evidence Disagrees
A balanced review of Jason Fung's bestseller: the reframe that genuinely helps people, where the insulin theory runs into the metabolic-ward studies, what the fasting trials really show, and how he suggests you eat.
Read more →
I Never Wanted to Push Myself in the Gym. Then I Treated It Like Medication.
I never wanted to push myself in the gym, my life was already hard. The shift was treating exercise and sleep with the same non-negotiable status as medication. The behavioural science of why we resist movement, and how to actually change it.
Read more →
Eat the Protein First: Why 500 Calories of Salmon Isn't 500 Calories of Chocolate
500 calories of salmon does something very different in your body than 500 calories of chocolate. The science of eating protein first, food order and blood sugar, and why your body keeps you hungry until it gets the protein it wants.
Read more →
The Case for Big Salads: Volume Eating for Losing and Maintaining Weight
Built well, a big salad is huge, filling and barely dents your calories for the day. The satiety research on energy density, protein and fibre, plus how I actually build mine.
Read more →
A Kilo Up After Two Holidays: How Much of It Is Actually Fat?
The scale jumped a kilo after a week away and your brain says a month of work is gone. The maths disagrees: glycogen, water and salt explain most of it. What the scale is really weighing, and what to do next.
Read more →
Two Magnums and a Wave of Guilt: How the All-or-Nothing Cycle Works, and How to Break It
One 'bad' food, a wave of shame, then either punishing restriction or the rest of the tub. The cycle has a name in behavioural science, decades of research, and a way out.
Read more →
Quitting GLP-1s: What Actually Happens, and How to Do It on Purpose
The withdrawal trials tell us what returns and how fast. Quitting is a phase to plan, not a cliff to fall off: the data, the biology, and the structure that helps.
Read more →
I Used to Think Potatoes Were Bad for Me. Then I Read the Satiety Research
Boiled potatoes top the satiety index at three times white bread, yet potato products top the weight-gain charts. Both are true, and the kitchen maths explains everything.
Read more →
Bodyweight Training on a GLP-1: Protecting the Weight You Want to Keep
A quarter to two-fifths of GLP-1 weight loss can be lean mass. Resistance training largely prevents it, and your own bodyweight is enough kit. The evidence plus a no-kit routine.
Read more →
How Are People Finding Orforglipron? Three Months of Real-World Reports
Foundayo launched in April 2026. What early users consistently praise, what they struggle with, and how the anecdotes square with the ATTAIN trial data.
Read more →
The 25mg Pill vs 0.5mg Injection Confusion: Why They're NOT the Same Dose
Why a 25mg oral GLP-1 pill and a 0.5mg injection aren't the mismatch they look like. Bioavailability explained, why there is no mg-to-mg conversion, and what the numbers really mean.
Read more →
Why Some People Choose the GLP-1 Pill Over the Needle (And What It Means)
Needle fear is common and keeps some people off GLP-1 injections. With the Wegovy pill now approved in the UK, here is what the pill option really means, and how well it works.
Read more →
Foundayo (Orforglipron): Doses, How to Take It, and How It Compares
Foundayo is the brand name for orforglipron, Lilly's once-daily GLP-1 pill, FDA approved April 1, 2026. Every dose from 0.8 to 17.2 mg, missed doses, side effects, and how it compares to Zepbound and Wegovy.
Read more →
How Healthcount Works: A Complete Walkthrough (Start Here)
A step-by-step tour of Healthcount, from sign up to your daily diary, dose schedule and trends. Everything you can track, what the icons mean, and how to get the most from it.
Read more →
What's Worth Buying on Your GLP-1 Weight-Loss Journey (and What to Skip)
What genuinely helps on a GLP-1, what to skip, and the order to spend in. Contains clearly marked paid links.
Read more →
Protein Powder and GLP-1s: The Good, the Bad, and What to Look For
Why protein matters so much on a GLP-1, how much you actually need, whey versus plant, what to look for on the label, and the marketing claims to ignore.
Read more →Wegovy Weight Loss Tracker: Your Whole Journey on One Dashboard
US guide to tracking your Wegovy journey: the 0.25 to 2.4 mg dose ladder, missed-dose rules from the FDA label, 2026 cash and insurance prices, and what to log each week.
Read more →Wegovy Pill Weight Loss Tracker: A Daily Routine You Can Actually Keep
How to track your Wegovy pill (oral semaglutide 25 mg) journey: the empty-stomach morning routine, the dose ladder, missed doses, weight trends, and food, all in one simple dashboard.
Read more →
Wegovy Pill: Doses and How to Take It (2026)
The Wegovy pill (oral semaglutide) from the FDA label: doses from 1.5 to 25 mg, the morning routine, missed doses, why it's taken on an empty stomach, and how it compares to the injection.
Read more →
Metabolic Syndrome and Your Desk Job: What Modern Work Does to Your Health
What metabolic syndrome is, how sitting all day, shift work and office snacking raise your risk of type 2 diabetes and heart disease, and what you and your employer can do about it.
Read more →
Your Period, Your Weight and Your Mood: What Really Happens Across the Month
Why the scale rises before your period (it's water, not fat), why you're hungrier in the second half of your cycle, and how to track your weight as a woman without the monthly panic.
Read more →
Does Your Environment Affect Your Weight? The Obesogenic Environment, Explained
Why your surroundings, not just willpower, shape your weight. The obesogenic environment explained, plus simple ways to design your home and workday for weight loss.
Read more →
Creatine: The Benefits for Body and Brain (and Why Women Needn't Fear It)
An evidence-based guide to creatine for body and brain: strength, muscle preservation, mood, safety and dosing. Plus why it's especially useful, and safe, for women and anyone on a GLP-1.
Read more →
Ultra-Processed Food and Weight: What the Science Actually Says
What ultra-processed food really is, what the strongest studies show about UPF and weight gain, and realistic swaps for busy people, without the food guilt.
Read more →
The Best Vegetables for Weight Loss: A Simple Tier List
A simple S-to-C tier list ranking vegetables by calories, fibre and protein. The best low-calorie and high-protein veg for weight loss, and where potatoes really fit.
Read more →
Low Calorie Snacks: The Best Picks and a Simple Swap Ladder
The best low calorie snacks ranked by how full they keep you, plus a swap ladder to gently step down from crisps, chocolate and biscuits. No banned foods.
Read more →
The Best Fruits for Weight Loss: A Simple Tier List
Not all fruit is equal for the calories. An S-to-C tier list ranking fruit by fibre, water and sugar, so you know which give the biggest nutrition for the fewest calories.
Read more →
Do You Weigh Food Raw or Cooked? How Cooking Changes the Calories
The same food has different calories per 100g depending on how it's cooked. Why raw vs cooked weight matters, the biggest offenders, and the simplest way to log accurately.
Read more →
How to Install the Healthcount App on iPhone & Android
No app store needed — add Healthcount to your home screen in a few taps. Step-by-step for iPhone (Safari) and Android (Chrome), plus troubleshooting.
Read more →
Can GLP-1s Help With Addiction and Alcohol? What the Science Says (US, 2026)
Could Ozempic, Wegovy or Zepbound help a family member drink less or beat an addiction? An honest, sourced look at the evidence on GLP-1s and alcohol, and where to get real help in the US.
Read more →
Free Alternative to Cronometer (2026): Why US Users Are Switching
A free Cronometer alternative for US users: macro tracking, AI meal photos, and GLP-1 dose logging for Zepbound, Wegovy, and Foundayo. No ads, no Gold tier.
Read more →
Free Alternative to MyFitnessPal (2026): No Ads, No Paywall, GLP-1 Ready
Want a free MyFitnessPal alternative without ads or a $19.99/month Premium tier? Healthcount offers macro tracking, AI meal photos, and GLP-1 dose and supply tracking for Zepbound, Wegovy, and Foundayo.
Read more →
Free Alternative to Lose It!: Everything Free, With GLP-1 Support Built In
Looking for a free Lose It! alternative? Healthcount gives you macro tracking, AI meal photos, and dose tracking for Zepbound, Wegovy, and the new GLP-1 pills. No ads, no Premium paywall.
Read more →
Is Shotsy Free? Shotsy Cost and a Free Alternative
Looking for a free Shotsy alternative that also tracks food? Healthcount logs Zepbound and Wegovy doses, side effects, weight, and macros in any browser. No subscription.
Read more →
GLP-1 Comparison Chart (2026): Zepbound, Wegovy, the Wegovy Pill and Foundayo
Zepbound, Wegovy, the Wegovy pill and Foundayo side by side: what each one is, how you take it, doses, each label's trial result and common side effects.
Read more →
Retatrutide vs Zepbound: What the Trials Actually Show (2026 US Guide)
A plain-English US comparison of investigational retatrutide and FDA-approved Zepbound (tirzepatide). Trial results, FDA status, side effects, real US access and cost, and what to track in Healthcount.
Read more →
How Much Tirzepatide Is Left in My Body After 1 to 7 Days? (Zepbound Half-Life, Explained)
Zepbound (tirzepatide) has a 5-day half-life. See how much of a dose is left after 1 to 7 days, a worked example of re-dosing early, and how long it takes to clear (about 30 days).
Read more →
Zepbound conversion to mL and units: why a full single-dose vial is 50 units
US conversion tables that map Zepbound vial draws to units, mL, and mg for every strength (2.5 to 15 mg). A full single-dose vial is 0.5 mL (50 units); a multi-dose vial dose is 0.6 mL (60 units).
Read more →Zepbound Dose Tracking App: a Simple Weekly Routine That Works
US guide to Zepbound (tirzepatide): the 2.5 to 15 mg dose ladder, missed-dose rules per the FDA label, pen vs vial formats, storage, and a simple weekly tracker.
Read more →